APA-viite (7. p.)
ROSENFELD, R. RESULTS FROM THE FIRST 2 YEARS OF A CLINICAL TRIAL WITH RECOMBINANT DNA-DERIVED HUMAN GROWTH HORMONE (SOMATREM) IN TURNER'S SYNDROME.
Chicago-viite (17. p.)
ROSENFELD, R.G. RESULTS FROM THE FIRST 2 YEARS OF A CLINICAL TRIAL WITH RECOMBINANT DNA-DERIVED HUMAN GROWTH HORMONE (SOMATREM) IN TURNER'S SYNDROME.
MLA-viite (9. p.)
ROSENFELD, R.G. RESULTS FROM THE FIRST 2 YEARS OF A CLINICAL TRIAL WITH RECOMBINANT DNA-DERIVED HUMAN GROWTH HORMONE (SOMATREM) IN TURNER'S SYNDROME.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.